Michael J. Holtzman

Affiliations: 
Washington University, Saint Louis, St. Louis, MO 
Area:
Cell Biology, Microbiology Biology, Molecular Biology, Public Health
Google:
"Michael Holtzman"
Cross-listing: PHTree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Holtzman MJ, Zhang Y, Wu K, et al. (2024) Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease. European Respiratory Review : An Official Journal of the European Respiratory Society. 33
Wu K, Zhang Y, Austin SR, et al. (2023) Lung remodeling regions in long-term Covid-19 feature basal epithelial cell reprogramming. The American Journal of Pathology
Wu K, Zhang Y, Austin SR, et al. (2022) Lung remodeling regions in long-term Covid-19 feature basal epithelial cell reprogramming. Medrxiv : the Preprint Server For Health Sciences
Hazan G, Eubanks A, Gierasch C, et al. (2022) Age-Dependent Reduction in Asthmatic Pathology through Reprogramming of Postviral Inflammatory Responses. Journal of Immunology (Baltimore, Md. : 1950)
Wu K, Kamimoto K, Zhang Y, et al. (2021) Basal-epithelial stem cells cross an alarmin checkpoint for post-viral lung disease. The Journal of Clinical Investigation
Wang X, Wu K, Keeler SP, et al. (2021) TLR3-Activated Monocyte-Derived Dendritic Cells Trigger Progression from Acute Viral Infection to Chronic Disease in the Lung. Journal of Immunology (Baltimore, Md. : 1950)
Katz-Kiriakos E, Steinberg DF, Kluender CE, et al. (2021) Epithelial IL-33 appropriates exosome trafficking for secretion in chronic airway disease. Jci Insight
Chen R, Wang L, Koch T, et al. (2020) Gender effects in the association between airway microbiome and asthma. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Hassan AO, Kafai NM, Dmitriev IP, et al. (2020) A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell
Winkler ES, Bailey AL, Kafai NM, et al. (2020) Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nature Immunology
See more...